Japan Isotretinoin Drugs Market

Growth Outlook

• The Japan Isotretinoin Drugs Market market is on a steady long-term growth path. Segment value stands at roughly USD 111 Mn in 2026 and is projected to reach USD 117 Mn by 2027 — a gain of about 6% over the forecast period, translating to a CAGR in the mid-single digits.
• By 2027, Capsule is the largest of the 14 groups tracked here, at 27. 98M USD, 24% of the combined total.
• What the regional split looks like (2026): Capsule leads, holding roughly 24% of segment value — the single largest regional share. Hospital Pharmacies is the second-largest contributor. Online Pharmacies , Injection, Severe Acne, Retail Pharmacies, Alpha Glucosidase Inhibitors, Squamous Cell Carcinoma, Cutaneous T-Cell Lymphoma, Neuroblastoma, Others, Harlequin Ichthyosis, Xeroderma Pigmentosum and Fibrodysplasia Ossificans Progressiva make up the remainder, in descending order.
• By 2027, Capsule alone is expected to reach USD 28 Mn, with Hospital Pharmacies at USD 19 Mn.

Market Dynamics

By 2027, Capsule is the largest of the 14 groups tracked here, at 27.98M USD, 24% of the combined total.

Hospital Pharmacies is runner-up at 19.15M USD — 32% off the lead.

Capsule climbs from 19.81M USD (2018) to 27.98M USD (2027), a 41% gain.

Hospital Pharmacies grows to 19.15M USD by 2027, from 13.85M USD in 2018 — 38% up.

Online Pharmacies: 6.42M USD to 11.43M USD, 78% higher by 2027.

Injection: up 60% over the period, 6.93M USD to 11.07M USD.

Severe Acne: 5.06M USD in 2018 to 8.93M USD by 2027, up 76%.

Retail Pharmacies climbs from 6.48M USD (2018) to 8.48M USD (2027), a 31% gain.

Online Pharmacies grows fastest of the group, 78% from 2018 to 2027 — starting smaller doesn't mean staying smaller at this pace.

Add every series together and the total reaches 117.17M USD by 2027, 46% above the 2018 combined figure of 80.24M USD.

How To Compare These 14 Groups

With 14 series on one chart, the shape that matters is how the ranking shifts over time, not just where each line starts or ends.

Do not confuse "biggest" with "fastest-growing" — they are frequently different series on a chart like this one, and the gap between them can close faster than the current ranking suggests.

Use this chart to size the Japan Isotretinoin Drugs market and to compare how fast it is expected to grow against adjacent markets — it works best as an input to a market-entry or investment decision, not as a standalone verdict.

Figures before the 2018 base year are historical estimates; the years through 2027 are projections built from industry data, company revenues, and primary interviews. Forecasts are revised as new data comes in, so check the full report for the latest assumptions.